香港引进重点企业办公室主任任景信接受《南华早报》访问时透露，正在与数间海外顶级制药企业接洽，其中至少有一间企业已取得可喜的成果。他提及，跨国制药公司阿斯利康(AZN.US) 已于香港设立总部。
任景信表示，将于未来数个月到访英国及法国，并指上述两国似乎有更多经济发展的动力，因而进一步拓展业务。他补充，英国近期积极派员访华，而且中法关系近期业很好。
另外，任景信承认引进办在吸引海外领先企业方面正面临更大挑战，但仍会努力增加海外企业的比例。他强调部门工作进展顺利，并已实现接触至少350间策略公司的目标，情况十分乐观。(js/da)(美股为即时串流报价； OTC市场股票除外，资料延迟最少15分钟。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.